Skip to main content

and
Your search also matched 9 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer

Include preview-only content
  1. Article

    Open Access

    Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells

    Although paclitaxel is a promising first-line chemotherapeutic drug for ovarian cancer, acquired resistance to paclitaxel is one of the leading causes of treatment failure, limiting its clinical application. Aspa...

    **n Zhang, Jiandong Wang, Yali Fan in Journal of Cancer Research and Clinical On… (2023)

  2. Article

    Correction to: BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion

    Ze-yu Yang, Su-peng Yin, Qingnan Ren, Deng-wei Lu, Tao Tang, Yao Li in Breast Cancer (2022)

  3. Article

    Camrelizumab combined with apatinib and S-1 as second-line treatment for patients with advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study

    The current second-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma remains unsatisfactory. Anti-PD-1 monoclonal antibody combined with anti-angiogenic therapy shows anti-tumor ac...

    Chao **g, Junyun Wang, Mingyue Zhu, Zhigang Bai in Cancer Immunology, Immunotherapy (2022)

  4. Article

    Open Access

    Alternative approaches to target Myc for cancer treatment

    The Myc proto-oncogene family consists of three members, C-MYC, MYCN, and MYCL, which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc, respectively. Myc protein orchestrates diverse physi...

    Chen Wang, Jiawei Zhang, Jie Yin, Yichao Gan in Signal Transduction and Targeted Therapy (2021)

  5. Article

    Open Access

    Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways

    The immune system initiates robust immune responses to defend against invading pathogens or tumor cells and protect the body from damage, thus acting as a fortress of the body. However, excessive responses cau...

    Jiaxin Liu, Yicheng Cheng, Ming Zheng in Signal Transduction and Targeted Therapy (2021)

  6. Article

    Open Access

    Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy

    Insulin-like growth factors (IGFs) play important roles in mammalian growth, development, aging, and diseases. Aberrant IGFs signaling may lead to malignant transformation and tumor progression, thus providing...

    Hui Hua, Qingbin Kong, Jie Yin, ** Zhang, Yangfu Jiang in Journal of Hematology & Oncology (2020)

  7. Article

    Open Access

    NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo

    NT1014 is a novel biguanide and AMPK activator with a high affinity for the organic cation-specific transporters, OCT1 and OCT3. We sought to determine the anti-tumorigenic effects of NT1014 in human ovarian c...

    Lu Zhang, Jianjun Han, Amanda L. Jackson in Journal of Hematology & Oncology (2016)

  8. Article

    Open Access

    Mutations in the D1 domain of von Willebrand factor impair their propeptide-dependent multimerization, intracellular trafficking and secretion

    We identified three novel mutations (p.Gly39Arg, p.Lys157Glu, p.Cys379Gly) and one previously known mutation (p.Asp141Asn) in the von Willebrand factor propeptide from three von Willebrand disease patients. Al...

    Jie Yin, Zhenni Ma, Jian Su, Jiong-Wei Wang in Journal of Hematology & Oncology (2015)